Goldman Sachs’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418M | Sell |
796,206
-40,887
| -5% | -$21.5M | 0.06% | 290 |
|
|
2025
Q1 | $531M | Buy |
837,093
+192,456
| +30% | +$122M | 0.09% | 206 |
|
|
2024
Q4 | $459M | Buy |
644,637
+35,594
| +6% | +$25.4M | 0.07% | 212 |
|
|
2024
Q3 | $640M | Sell |
609,043
-79,536
| -12% | -$83.6M | 0.1% | 156 |
|
|
2024
Q2 | $724M | Buy |
688,579
+307,658
| +81% | +$323M | 0.12% | 130 |
|
|
2024
Q1 | $367M | Buy |
380,921
+9,136
| +2% | +$8.79M | 0.07% | 266 |
|
|
2023
Q4 | $327M | Sell |
371,785
-21,385
| -5% | -$18.8M | 0.06% | 287 |
|
|
2023
Q3 | $324M | Sell |
393,170
-108,860
| -22% | -$89.6M | 0.07% | 230 |
|
|
2023
Q2 | $361M | Buy |
502,030
+66,252
| +15% | +$47.6M | 0.08% | 209 |
|
|
2023
Q1 | $358M | Sell |
435,778
-126,927
| -23% | -$104M | 0.08% | 208 |
|
|
2022
Q4 | $406M | Buy |
562,705
+130,790
| +30% | +$94.4M | 0.1% | 172 |
|
|
2022
Q3 | $298M | Buy |
431,915
+16,790
| +4% | +$11.6M | 0.08% | 221 |
|
|
2022
Q2 | $245M | Buy |
415,125
+37,578
| +10% | +$22.2M | 0.06% | 285 |
|
|
2022
Q1 | $264M | Buy |
377,547
+1,902
| +0.5% | +$1.33M | 0.06% | 302 |
|
|
2021
Q4 | $237M | Sell |
375,645
-77,147
| -17% | -$48.7M | 0.05% | 340 |
|
|
2021
Q3 | $274M | Buy |
452,792
+96,267
| +27% | +$58.3M | 0.06% | 279 |
|
|
2021
Q2 | $199M | Sell |
356,525
-6,203
| -2% | -$3.46M | 0.04% | 358 |
|
|
2021
Q1 | $172M | Buy |
362,728
+127,994
| +55% | +$60.6M | 0.04% | 367 |
|
|
2020
Q4 | $113M | Sell |
234,734
-302,210
| -56% | -$146M | 0.03% | 479 |
|
|
2020
Q3 | $301M | Buy |
536,944
+41
| +0% | +$23K | 0.09% | 183 |
|
|
2020
Q2 | $335M | Buy |
536,903
+17,886
| +3% | +$11.2M | 0.1% | 168 |
|
|
2020
Q1 | $253M | Sell |
519,017
-159,339
| -23% | -$77.8M | 0.09% | 186 |
|
|
2019
Q4 | $255M | Buy |
678,356
+235,055
| +53% | +$88.3M | 0.06% | 286 |
|
|
2019
Q3 | $123M | Sell |
443,301
-163,168
| -27% | -$45.3M | 0.04% | 495 |
|
|
2019
Q2 | $190M | Buy |
606,469
+5,741
| +1% | +$1.8M | 0.05% | 358 |
|
|
2019
Q1 | $247M | Buy |
600,728
+89,862
| +18% | +$36.9M | 0.07% | 249 |
|
|
2018
Q4 | $191M | Sell |
510,866
-37,905
| -7% | -$14.2M | 0.06% | 298 |
|
|
2018
Q3 | $222M | Buy |
548,771
+41,589
| +8% | +$16.8M | 0.06% | 342 |
|
|
2018
Q2 | $175M | Sell |
507,182
-146,982
| -22% | -$50.7M | 0.05% | 421 |
|
|
2018
Q1 | $225M | Buy |
654,164
+154,823
| +31% | +$53.3M | 0.06% | 340 |
|
|
2017
Q4 | $188M | Buy |
499,341
+113,282
| +29% | +$42.6M | 0.04% | 415 |
|
|
2017
Q3 | $173M | Buy |
386,059
+13,792
| +4% | +$6.17M | 0.04% | 431 |
|
|
2017
Q2 | $183M | Buy |
372,267
+39,299
| +12% | +$19.3M | 0.05% | 385 |
|
|
2017
Q1 | $129M | Buy |
332,968
+5,452
| +2% | +$2.11M | 0.04% | 520 |
|
|
2016
Q4 | $120M | Sell |
327,516
-581,949
| -64% | -$214M | 0.03% | 536 |
|
|
2016
Q3 | $366M | Sell |
909,465
-5,235
| -0.6% | -$2.1M | 0.11% | 134 |
|
|
2016
Q2 | $319M | Buy |
914,700
+171,592
| +23% | +$59.9M | 0.1% | 145 |
|
|
2016
Q1 | $268M | Sell |
743,108
-92,514
| -11% | -$33.3M | 0.09% | 196 |
|
|
2015
Q4 | $454M | Buy |
835,622
+453,676
| +119% | +$246M | 0.14% | 105 |
|
|
2015
Q3 | $178M | Buy |
381,946
+29,957
| +9% | +$13.9M | 0.06% | 280 |
|
|
2015
Q2 | $180M | Buy |
351,989
+11,521
| +3% | +$5.88M | 0.06% | 310 |
|
|
2015
Q1 | $154M | Buy |
340,468
+119,764
| +54% | +$54.1M | 0.05% | 371 |
|
|
2014
Q4 | $90.5M | Sell |
220,704
-151,446
| -41% | -$62.1M | 0.03% | 542 |
|
|
2014
Q3 | $134M | Sell |
372,150
-787,522
| -68% | -$284M | 0.04% | 386 |
|
|
2014
Q2 | $328M | Buy |
1,159,672
+100,882
| +10% | +$28.5M | 0.1% | 158 |
|
|
2014
Q1 | $318M | Sell |
1,058,790
-214,574
| -17% | -$64.4M | 0.1% | 154 |
|
|
2013
Q4 | $350M | Buy |
1,273,364
+9,176
| +0.7% | +$2.53M | 0.12% | 135 |
|
|
2013
Q3 | $396M | Buy |
1,264,188
+27,790
| +2% | +$8.69M | 0.15% | 96 |
|
|
2013
Q2 | $278M | Buy |
+1,236,398
| New | +$278M | 0.11% | 141 |
|